Ultragenyx Pharmaceutical Inc. has grown revenue 21% a year over three years and 15% a year over five. Revenue growth, 3-year annual rate: +21% (Biotechnology median +21%). Revenue growth, 5-year rate: +15%, growth has picked up over the last three years. Years of annual history on file: 14, FY2012 to FY2025, as filed.

RAREUltragenyx Pharmaceutical Inc.

HealthcareUSD

$26.47

$18.5052 weeks$36.54

Is it growing?

Is RARE growing?

Ultragenyx Pharmaceutical Inc. has grown revenue 21% a year over three years and 15% a year over five.

+21%

Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +15%
Revenue growth, 5-year rate · +21% over three · growth has picked up over the last three years
Years of annual history on file: 14
Years of annual history on file · FY2012 to FY2025, as filed

Details›